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Associate Professor, Department of Radiation Oncology 
Recently, there has been interest to integrate VMC++ into the commercial treatment 
planning system at VCU as another Monte Carlo code option, since it has been shown to 
increase efficiency dramatically without introducing a significant amount of systematic 
error. Also, independent validation of VMC++ for photon beams is of interest since this 
has not been performed previously in literature. This study included several tests 
required to integrate VMC++. Output factor normalization was performed and found to 
agree with experiment to within 1% for all field sizes except 1x1 cm2. Geometric 
validation was successful. Dosimetric validation was performed with respect to 
DOSXYZnrc on a water phantom, resulting in agreement within statistical uncertainty 
except for slight differences at the surface of the phantom. Dosimetric comparison was 
made for a head-and-neck patient case, showing that 5% of the voxels did not agree 
within 2.8% of maximum dose. The ability of VMC++ to compute dose-to-water was 
compared to an in-house algorithm and found to agree within statistical uncertainty. 
1 Introduction 
1.1 Radiation Therapy Background 
Radiation therapy first became possible when Wilhelm Roentgen discovered X-rays in 
1895. At first, only low-energy radiation was available through use of specially designed 
vacuum tubes and expensively refined radium. While many positive outcomes were 
heralded, such as treatment of skin cancers, some unexpected side effects were also 
produced, such as skin reddening and scarring. Not until 1948 were megavoltage beams 
introduced by Donald Kerst's betatron. High energy X-rays proved to be a successful 
non-invasive modality against cancer. Not only did an external beam of these rays 
destroy tumors, but it also spared the skin from damage if used  correct^^.'^ 2' 
In designing an effective radiation treatment plan for a cancer patient, it is of 
utmost importance to understand where and how the dose will be deposited by the 
radiation. Planning of this treatment became much more precise with the advent of 
computerized tomography (CT) in the 1970's. By using CT, important volumes or 
structures in the body could be more precisely located and labeled. In an ideal treatment 
the tumor volume should be covered completely by a lethal dose, while other sensitive 
volumes such as the spinal cord should be limited to a low level of dose to avoid any 
damage or side-effects. 
1.2 Treatment Planning 
Treatment planning, simply put, is the planning of radiation treatment for a patient. 
Beam angles and the number of monitor units (a measure of machine output for a linear 
accelerator) are set such that the tumor volume(s) will receive a prescribed dose, while 
organs at risk will receive minimal dose. To aid in the planning, a treatment planning 
system (TPS) is used. The TPS is a computer program which incorporates treatment plan 
information, including beam information, prescribed dose, and computed dose, along 
with patient CT scans. 
Treatment planning has become much more complex recently with the advent of 
intensity-modulated radiation therapy (IMRT). In this method each incident beam is 
modulated such that some areas of the beam have greater intensity and some areas have 
lesser intensity. This modulation results in greater sparing of normal tissue while higher 
dosing of the tumor volume. In areas where the tumor is concentrated, the beam is 
focused more intensely, whereas in areas where the tumor is not as concentrated, the 
beam is focused less intensely. 
1.3 Dose Calculation 
When a treatment plan is prescribed, the dose must be calculated before delivered. Two 
important factors in this calculation are accuracy and time. There is no reason to use an 
extremely accurate dose calculation algorithm if it requires weeks to complete. On the 
other hand, if the process takes five minutes to complete, but is not accurate, error is 
introduced into the plan due to the lack of accuracy. Thus, it is of importance that the 
calculation be accurate, while not time consuming. While the overall accuracy of 
delivered dose has been recommended to be less than 5%4, the accuracy of calculated 
dose has been recommended to be 3-4%.5 
One way to gain insight into the distribution of dose from an external beam is to 
use a water phantom. Dosimeters may be placed strategically in the phantom to give an 
understanding of the distribution of dose. Since the density and average atomic weight of 
water closely resemble that of the human tissue, the distribution of dose in a water 
phantom may be used to predict how dose would be deposited in the human body. In 
order to understand how different materials in the body such as bone would affect the 
distribution, bone-like objects may be placed in the phantom as well. For clinical 
purposes, however, water phantom models are not practical considering the significant 
differences between patients. Not only is it impractical to insert dosimeters into a patient 
for dose monitoring, but the resulting dose distribution also would not be accurate with a 
limited number of dosimeters. 
Analytical dose calculation methods such as pencil beam, collapsed cone 
convolution, and superposition/convolution are current popular choices of dose 
calculation in TPSs. While these methods do not exactly model the way that dose is 
distributed in a plan, they give a reasonable approximation. Calculation time is less than 
an hour. Several factors are added into the calculation to account for lateral scatter and 
attenuation. However, it should be noted that limitations of these analytical algorithms 
exist in geometries containing complex h e t e r ~ ~ e n e i t i e s . ~  At Virginia Commonwealth 
University (VCU) a superposition/convolution technique is used which only requires a 
few minutes to compute. 
The dose calculation method with potentially the highest accuracy is Monte 
~ a r l o . ~ '  A computer can simulate particles in a beam and predict how they will interact 
in a material. Since cross-sections and angular distributions of interactions have already 
been determined experimentally, the computer can use these data to correctly transport 
particles through media. These simulations have been called Monte Carlo simulations 
since the computer is using random selection to determine how the particles are 
transported. The Monte Carlo method will be more descriptively introduced in chapter 
two of this work. The two families of codes tested in this thesis, Electron Gamma 
Shower (EGS) and Voxel Monte Carlo (VMC) will be discussed more in depth in chapter 
two as well. 
1.4 Thesis Objectives 
VCU currently has a TPS capable of calling several Monte Carlo codes, including 
DOSXYZnrc of the EGSnrc family. Recently, there has been interest to integrate 
VMC++ into the system as another Monte Carlo code option, since it has been shown to 
increase efficiency dramatically without introducing a significant amount of systematic 
error. Also, independent validation of VMC++ for photon beams is of interest since this 
has not been performed previously in literature. This thesis will cover the following tests 
necessary for integration of VMC++: geometric validation, phantom dosimetric 
validation, and patient dosimetric comparison with DOSXYZnrc. The accuracy and 
efficiency of VMC++ will be benchmarked to that of DOSXYZnrc, including a further 
study looking into the dose-to-water conversion used by VMC++. 
Chapter two of this thesis gives a description of the Monte Carlo process, while 
also describing the history and specifics of VMC++. Chapter three explains how 
DOSXYZnrc and VMC++ are integrated into the TPS at VCU. In chapter four phase 
space source integration and output factor normalization are discussed. Phantom 
geometric validation is carried out in chapter five. Chapter six covers phantom 
dosimetric validation and patient dosimetric comparison. Chapter seven compares the 
dose-to-water calculation performed by VMC++ to that performed by an in-house VCU 
program. Conclusions are summarized in chapter eight. 
2 Monte Carlo 
2.1 The Monte Carlo Method 
The Monte Carlo method involves transporting particles through a defined geometry. 
Each original particle that is transported through the geometry is termed a 'history'. 
When a particle is transported, the computer randomly decides several factors, including 
the distance to the particle's next collision, what type of collision it will undergo, and 
what angle and energy with which it will exit the collision. Each random choice the 
computer makes is called a 'sample'. A random number is chosen on the range [0,1], to 
which a probability density function (PDF) is mapped. An example of a collision-type 
PDF is shown in Figure 1. 
The basic flow of a Monte Carlo simulation for each history is as follows: 
1) Sample the particle's initial energy, position, and direction from a source PDF. 
2) Sample the distance to the particle's next collision, based on the material(s) 
through which the particle is being transported. Take note of the voxel (three- 
dimensional pixel) in which this collision occurs. If the distance places the 
particle outside of the geometry, terminate the particle history. 
3) Sample the collision from the PDF corresponding to the surrounding material and 
the particle energy. If the sampled collision results in the particle being absorbed, 
terminate the particle history. If the particle is not absorbed, sample its outgoing 
direction and energy. If the particle's outgoing energy is below a cutoff energy, 
terminate the particle history. If the sampled collision produces a new particle, 
store the new particle on a stack for its own sampling later. 
4) Score a correct deposition of dose in the voxel in which the particle interacted. 
5) Repeat steps two through four until the particle is absorbed or leaves the 
geometry. 
6) For every extra particle created by a collision in step three, cycle through steps 
two through five for the new particle until its history is terminated. 
7) Add together all depositions of dose for particles existing in the current history. 
8) Calculate the sum of all history scores, along with respective absolute 
uncertainties, defined as 
where N is the number of primary histories and Xi is contribution to the scored 
dose by independent history i.9 
9) Repeat steps one through eight for a total number of histories or until a desired 
uncertainty is obtained. 
To understand the finer details of Monte Carlo sampling, the reader is encouraged to read 
Williamson's chapter in Monte Carlo Simulation in the Radiological ~ciences." 
A major roadblock to Monte Carlo simulation lies in the amount of time required 
for its execution. One source of spent time lies in all of the sampling required per 
particle. Each particle must have a distance, direction, and collision sampled for every 
collision until it is absorbed. Since photons only undergo several interactions before 
being absorbed, the time spent sampling for them is not critical. However, for electrons, 
which typically undergo -lo6 collisions before absorption, the sampling time simply 
requires too much computing time. 
Variance reduction techniques (VRTs) are used to reduce the amount of time 
required for a Monte Carlo simulation, while not sacrificing the accuracy of the 
calculation. VRTs are implemented in order to gain efficiency, which is defined as 
where a2 is the statistical variance and t is the computing time required for the 
simulation. The most common VRT used in Monte Carlo simulations is electron 
condensed history (CH). This technique, first proposed by ~ e r ~ e r "  in 1963, drastically 
reduces the amount of time required to transport electrons by realizing that the majority 
of the collisions that electrons experience only slightly affect their energy and direction. 
Samples are only taken at every major "knock-on" collision, thereby increasing 
efficiency, while not introducing significant systematic bias. It was not until two decades 
later that CH was theoretically justified by ~ a r s e n ' ~ .  A second common VRT is found in 
history repetition. Using this technique, a history may be repeated several times as long 
as it is started at a different location each instance. Every time the history is repeated, 
efficiency is increased since no new sampling needs to be performed.'3 
Even though Monte Carlo's accuracy is potentially higher than that of 
conventional algorithms, its accuracy comes at the cost of computation time. Since its 
statistical uncertainty is indirectly related to the number of histories squared, computation 
time must be quadrupled in order to reduce the uncertainty by a factor of two. However, 
as advances in computer technology are made, and as more VRTs are utilized, the 
computation time decreases accordingly. In order to replace analytical dose calculation 
methods in the clinic, the computation time of Monte Carlo must be lowered to a level 
comparable to that of the analytical methods. 
One of the most commonly used Monte Carlo codes is the Electron-Gamma-Shower 
(EGS) family of codes.14 In the early 1970's the first version of EGS was produced by 
Ford and Nelson. It was then benchmarked against various experiments and compared to 
other Monte Carlo results, and found to have good agreement. Since then, the code has 
been improved several times (EGS2 in 1975, E G S ~ ' ~  in 1978, E G S ~ ' ~  in 1985, 
E G S ~ ~ C ' ~ > ' *  in 2000), while being benchmarked continuously. For this reason, it is 
considered a good standard of comparison for other Monte Carlo transport codes. 
D O S X Y Z ~ ~ C ' ~  is a Monte Carlo simulation code, which uses voxels to calculate a 
dose distribution. It is a member of the EGSnrc family of codes and was upgraded from 
DOSXYZ in 2001. DOSXYZnrc is a very flexible code insofar that it can have several 
beams incident on the phantomlpatient while also being able to use phase space input 
files. 
2.3 Voxel Monte Carlo 
In the mid 1990s Kawrakow, Fippel, and ~riedrich~' developed a new electron transport 
Monte Carlo code, which they named Voxel Monte Carlo (VMC). Their code was 
specifically for use of radiation therapy dose calculations in voxelized phantoms. One of 
the main reasons they did this was because they realized the conventional code being 
used at the time, EGS4, was designed to describe electron transport in all materials in a 
very wide energy range (from a few keV to GeV energies). They reasoned that for 
radiation treatment planning (RTP), only materials of density less than 3&m3 and 
energies in the 1-30 MeV range were of interest. Using several simplifications and 
approximations, a 35x higher efficiency was obtained for electron transport compared to 
EGS4 for electron beam simulations. First of all, they introduced history repetition as a 
VRT, while only adding less than one percent of systematic error. Secondly, they 
reduced the average number of electron steps per history by allowing electrons to proceed 
through boundaries in a single CH step. This is a two step process. First, electrons are 
transported through a homogeneous water medium with different CH steps defined in 
terms of energy loss. Secondly, these histories are applied to a voxelized heterogeneous 
geometry. This application requires rescaling of the path length of each step by a ratio of 
the voxel-dependent stopping power to that of water, thereby keeping the energy lost in 
the step equal to that lost in the step in water. The energy deposited in each voxel is 
calculated by multiplying the stopping power of the voxel by the distance traversed by 
the electron through the voxel. In addition to the energy loss, the electron scattering 
angle at the end of the step requires rescaling due to the material dependence of the 
scattering angle. Utilizing these methods, several voxels of various materials can be 
crossed in one CH step. The reduction of total CH steps per history resulted in an 
efficiency gain of up to 150 times2' over EGS4, which terminates CH steps at every 
interface using its boundary crossing algorithm, PRESTA~~ (parameter-yeduced glectron 
step transport algorithm). Thirdly, bremsstrahlung photons were discarded since their 
- 
contribution to the overall dose was insignificant in RTP range. Whenever a 
bremsstrahlung photon was produced, its energy was simply subtracted from the electron 
that produced it. Fourthly, the previously complex cross section for producing delta 
particles was simplified while producing negligible effects. Finally, it was noted that 
even with an underestimation of large-angle elastic scattering due to the previous 
simplification, the dose distribution was unaffected. Another improvement of VMC was 
that it required no large amounts of precalculated data. Because of VMC's dramatic 
increase in efficiency and subsequent decrease in computing time, its creators boldly 
concluded: "We therefore consider the VMC model to be a serious alternative to pencil- 
beam algorithms." 
In 1998 ~ i ~ ~ e 1 ~ ~  went on to expand the horizons of VMC by applying it to photon 
transport as well. Because of the inclusion of photon transport, he renamed the code 
XVMC. When compared to EGS4, XVMC was more efficient by a factor of 15-20. This 
increase in efficiency was due to: 1) the previous increase in efficiency for electron 
transport in VMC, 2) a fast ray tracing technique, and 3) the initial ray tracing technique, 
which determined the number of electrons created in each voxel by the primary photon 
beam. In 1999 Kawrakow and ~ i ~ ~ e 1 ~ ~  applied several more VRTs to improve XVMC: 
1) interaction forcing: photons were forced to interact before they exited the geometry. 
Otherwise, all of the time sampling for the photon would be wasted. 2) Quasi-random 
sequences were used instead of pseudo-random numbers. These sequences are more 
efficient at uniformly filling a space. 3) Woodcock tracing2' was used so that 
heterogeneous media would not require time-consuming ray tracing. In this method, the 
photon is transported through a heterogeneous medium as though it were a homogeneous 
medium formed by the most dense material from the heterogeneous medium. The photon 
is then weighted by the ratio of the attenuation coefficient of the material in which the 
photon is initially located divided by that of the most dense material. 4) Photon splitting, 
similar to history repetition for electrons, was used. An overall efficiency gain of 3.5-1 1 
was made over the previous XVMC code. The new XVMC code had an efficiency 50 to 
80 times higher than EGS4. 
~ a w r a k o w ~ ~  introduced the newest installation of VMC in 2000: VMC++. This 
new version was written using C++ and benefited from its object-oriented design. Every 
interaction relevant to the simulation was represented by a separate interaction object. 
Implementation of improvements and modifications to the code also became much easier. 
VMC++ became a much more flexible code than its predecessors. The major new VRT 
introduced in VMC++ was the use of Simultaneous Transport Qf Particle Sets (STOPS). 
This technique was similar to history repetition, but instead of just repeating one electron 
at a time, entire sets of electrons with equal energies were repeated. By using STOPS, 
several variables such as interpolation indexes, azimuthal scattering angles, and distances 
to the next collision could be sampled just once for an entire set of particles. The largest 
gain in efficiency was achieved when roughly forty electrons per set were transported by 
STOPS. VMC++ also extended the use of quasi-random sequences to electron beams. 
When combined with STOPS, the quasi-random sequences yielded an efficiency gain of 
about five times. 
3 MCV Monte Carlo Flow 
The TPS used at VCU is ADAC Pinnacle (Philips Medical System). Either a 
user-defined phantom may be created or CT slices may be imported for dose calculation. 
Multiple beams can be simulated at arbitrary source-to-surface distances (SSDs) and at 
user-defined gantry, collimator, and couch angles rotated about a user-defined isocenter 
(the point about which the gantry rotates). The prescription can be set at a certain amount 
of monitor units (MUs). The dose grid may also be created, thereby defining voxel size. 
After simulation, user-defined isodose lines may be displayed over top of the phantom or 
CT image. One useful feature of Pinnacle is its ability to call other codes. One of its side 
menus shows a list of user-defined 'hot scripts', which serve a variety of functions. At 
VCU, hot scripts have been developed which range from extracting depth dose data to 
calling Monte Carlo dose calculation codes. Pinnacle also allows for planning of 
multiple trials, each with its own specific treatment plan. 
The system of programs used to perform various Monte Carlo codes at VCU was 
developed by Siebers et This system is referred to as mcvmc (Medical College of 
Virginia Monte Carlo). A flow diagram is shown in Figure 2. Mcvmc is a program 
written in the C++ programming language which reads beam parameters from Pinnacle, 
creates input files for Monte Carlo codes which simulate the treatment delivery, submits 
jobs to (multiple) selected computers to perform the Monte Carlo simulation, collects and 
merges results from the MC simulations, and inputs the final dose distribution back into 
Pinnacle. By selecting different options in mcvmc, one can tailor the Monte Carlo codes 
which are run for a given test case (e.g. can select  BEAM^^ or BEAMnrc, or can select 
DOSXYZ, DOSXYZnrc, or VMC++). In this study mcvmc was used to ensure that 
DOSXYZnrc and VMC++ would use the same incident particles on phantodpatient 
geometry, so that any differences in results could be attributed to the differences in those 
two codes. 
3.1 Graphical User Interface for mcvmc 
The 'hot script' which is used to call VMC++ is called mcvmc.vmc (mcvmc, with 
VMC++ capabilities). This script calls the mcvmc.vmc.tc1 file, which produces a 
graphical user interface (GUI) between Pinnacle and mcvmc, which allows the user to set 
options and flags to be passed to mcvmc, as seen in Figure 3. The user may either run 
Monte Carlo with the standard defaults, or helshe may alter them in the Config menus to 
setup the desired simulation. 
The general config window is seen in Figure 4. The first option, 'Compute 
Density Grid', sets a flag to run ct-create19, a code that derives materials from CT 
information. At VCU the CT information is translated into a range of fifty-six materials, 
which very accurately model the various tissues found in the human body. The second 
option, 'Compute Phase Space', sets a flag to run BEAM or BEAMnrc, codes which 
simulate particle transport through the accelerator head and store the resulting particles in 
a phase space. The third option, 'Compute Patient Dose', sets a flag to run the Monte 
Carlo code, which transports the particles through the phantodpatient CT. The fourth 
option, 'Load Dose Files', sets a flag to load the dose back into Pinnacle so that the user 
may view the resulting dose distribution. The first pull down menu allows the user to 
choose which code to generate the phase space with: BEAM or BEAMnrc. In this study 
BEAM was used. The second pull down menu allows the user to choose which code to 
simulate particles through the phantodCT images: DOSXYZ, DOSXYZnrc, MCVRTP, 
or VMC++. Two pull down menus further down allow the user to choose which 
computer to run mcvmc from, and which appropriate cluster to run the Monte Carlo 
subprocesses on. Finally, the user may define the desired relative uncertainty to run the 
Monte Carlo code to; the default value is set at two percent. 
The more specific config menus, the DMLC (dynamic multi-leaf collimator) 
config menu, the VMC++ config menu, and the research config menu, are seen in Figure 
5, Figure 6, and Figure 7, respectively. The DMLC config menu allows the user to 
choose if and how particle transport through the DMLC should be simulated, as in the 
case when using IMRT fields. The VMC++ config menu lets the user choose whether 
VMC++ should compute dose-to-water or dose-to-material (see chapter 7 below). Also, 
the user may choose whether a source model is being used or if particles are being 
sampled from a phase space. The photon splitting factor (a type of VRT) may either be 
set to equal that of DOSXYZnrc or independently set by using the slider at the bottom of 
the menu. Finally, the research config menu gives the user the option of deleting old 
phase space data files, causing the subsequent mcvmc run to calculate new ones. If this 
option is left unchecked, the subsequent mcvmc run will simply use the old files. Also of 
importance is the option to run the beta version of the code, which is valuable for testing 
new changes to the code. 
Another important function of the mcvmc.vmc.tc1 code is to create a basic 
VMC++ input file (see Appendix A). This input file records several data for VMC++. 
First of all, it records whether a source model is being used to simulate particles or if 
particles are being taken from phase space (see below for an explanation of phase space). 
In this study, particles were always taken from phase space, which was previously 
generated by a BEAM simulation through the accelerator head. Secondly, the input file 
records beam geometry and secondary jaw positioning. Also of importance, it records 
the phantom CT data file, dose scoring options, variance reduction options, and the 
desired uncertainty. 
A final important function of the mcvmc.vmc.tc1 code is to call the next code in 
the chain, tcl-to-mcv (see next section). A new terminal window is opened, and all of 
the flags and values set by the user in each of the config menus as well as any default 
flags and values are passed to tcl-to-mcv. 
3.2 Parallelization of the Process 
Tcl-to-mcv is a c-shell code that is called by mcvmc.vmc.tc1 and is passed all of the flags 
and values from that code. Since the simulation will not necessarily be run on the same 
computer on which Pinnacle is being run, scripts containing all of the flags and values 
must be copied to the appropriate machine(s). The tcl-to-mcv code then calls either the 
mcvmc code or the mcvmc.beta code, depending on whether the beta version was 
selected or not, and passes along the flags and values. 
3.3 mcvmc Code 
The mcvmc code is a C++ code, which first determines if the flags and values passed to it 
are logically consistent with each other and if they are in the proper ranges. It then loops 
over all beams and calls a subroutine, compute~mcvmc~beams, to perform the selected 
processes. Upon successful completion, mcvmc reports normal termination. The core of 
the run lies in the compute~mcvmc~beams subroutine, where commands are given to run 
each beam through the accelerator head, and then through the phantom geometry using 
the simulation code previously selected by the user. This is also where the photon 
splitting factor is computed such that VMC++ replicates DOSXYZnrc, if the user desired 
so. Finally, the time elapsed for each run is displayed. 
3.4 Calling VMC++ 
If the VMC++ flag is set, runVMC is called. This code substitutes the last several 
variables into the VMC++ input file created earlier by mcvmc.vmc.tc1. These variables 
include the phase space file name, the VMC++ phantom file name, the phase space z- 
distance, the number of particles to be run, the photon splitting factor (which was derived 
in compute~mcvmc~beams.cc), and two random seeds. After the input file is edited, 
runVMC calls runVMCStandAlone, which remotely executes VMC++ on the input file. 
Once VMC++ produces a dose distribution, another program is required to convert the 
VMC++ dose distribution to one that is readable by Pinnacle, since the two have different 
formats. It should be noted that all other available Monte Carlo codes are implemented in 
a similar fashion as VMC++ (i.e. runBEAM, runDOSXYZ, etc.. .). 
4 Integration of VMC++ 
4.1 Phase Space Source Integration 
Code was developed so that a phase space source could be integrated into VMC++ as an 
allowable input. A phase space is a file which contains information about particles, 
including position, direction, energy, and weight (how much each particle is weighted). 
The particles which are transported through the accelerator head by BEAM are stored in a 
phase space and subsequently used as a source of incident particles to be transported 
through the phantom geometry by a dose calculation code. The phase space source code 
was modified by Siebers so that it would fit into the mcvmc family of codes, as well as 
perform a rotationltransformation changing the accelerator coordinates to the patient 
coordinates before transport through the phantom was carried out. The rotation matrix 
used was borrowed from an in-house code which had required the exact same rotation for 
DOSXYZ. 
4.2 Output Factor Normalization 
Since Monte Carlo computes dose per incident particle, and not dose per MU, the output 
must be multiplied by a particles-per-MU factor. This factor must be scaled properly 
such that VMC++ results are consistent with DOSXYZnrc. If the VMC++ result is 
multiplied by the correct factor, all field size distributions should match DOSXYZnrc 
predictions. 
4.2.1 Method 
Pinnacle was used to create a 10x10 cm2 6MV photon beam orthogonally incident on a 
rectangular water phantom (48cm x 48cm x 41cm depth), which resembled a Wellhofer 
3d phantom (Scanditronix Wellhofer North America). Since the resolution of the depth 
dose curves were of primary importance, the dose grid was created to form voxels with a 
cross section of 2x2 cm2, and depth of 0.5 cm. The voxels completely covered the depth 
of the phantom while also covering 46 cm of the 48 cm length and width. Both 
DOSXYZnrc and VMC++ were run using the same particles from phase space to a 
nominal statistical uncertainty of 0.5%. In order to calculate the particles-per-MU factor, 
a method proposed by Siebers et aP9 was used. The DOSXYZnrc and VMC++ depth 
dose curves were integrated from 5 cm to 15 cm depth. The VMC++ results were then 
multiplied by the ratio of the integrated DOSXYZnrc dose divided by the integrated 
VMC++ dose. 
For the following field sizes, the VMC++ output was multiplied by the ratio 
determined for the 10x10 cm2 field by the process above. Field sizes of 1x1 cm2, 2x2 
cm2, 4x4 cm2, 10x10 cm2, 20x20 cm2, and 40x40 cm2 at energy 6MV were simulated, 
and field sizes of lx  1 cm2, lox 10 cm2, and 40x40 cm2 at energy 18MV were simulated. 
It should be noted that for fields smaller than 10x10 cm2, voxel sizes were reduced to 0.3 
cm in the lateral directions to yield higher in-beam resolution. 
Output factors normalized to the 10x10 cm2 field were calculated for both 
DOSXYZnrc and VMC++. The DOSXYZnrc and VMC++ output factors were then 
compared to experimental data collected using a Wellhofer 3d water phantom and IC3 
ionization chambers (from Wellhofer). 
4.2.2 Results 
It was found that the integral of the depth dose curve of VMC++ between 5 cm and 15 
cm depth differed from that of DOSXYZnrc by a factor of 1 . 0 0 2 ~ 1 0 ~ ' ~  & 0 .004~10- '~  for
the 10x10 cm2, 6MV field. After communication with the author of VMC++, it was 
learned that VMC++ produces dose distributions multiplied by a factor of 1.0x10-'~ 
Gylincident particle. Since the results were within statistical uncertainty of this factor, 
1.0x10-'~ was used as the normalization factor in all other calculations. When this factor 
was multiplied into all VMC++ calculations, the depth dose curves of the two Monte 
Carlo codes lined up within statistical uncertainty. The depth dose curves for the 1x1 cm2, 
10x10 cm2, and 40x40 cm2 fields at energy 6MV may be seen in Figure 8. The depth 
dose curves for the 2x2 cm2, 4x4 cm2, and 20x20 cm2 fields at energy 6MV may be seen 
in Figure 9. The depth dose curves for the 1x1 cm2, 10x10 cm2, and 40x40 cm2 fields at 
energy 18MV may be seen in Figure 10. 
At several field sizes, VMC++ noticeably (i.e. greater than two standard 
deviations) underpredicts the surface dose calculated by DOSXYZnrc. This 
underprediction is due to the differing ways in which the codes handle electrons as they 
pass under the electron cutoff energy. For DOSXYZnrc, when an electron's energy 
passes below the cutoff energy, it is terminated and the dose is deposited in the current 
voxel. For VMC++, when the electron's energy passes below the cutoff energy, the 
electron takes a step equal to its residual range, which is assumed to be a straight line24. 
The dose is then deposited along this step. To test if the difference in handling electrons 
when they pass below the cutoff energy is the reason for the differing surface doses, 
DOSXYZnrc was run at three different cutoff energies (887 keV, 189 keV, and 50 keV 
kinetic energy), while VMC++ was run at two different cutoff energies (887 keV and 
43.6 keV).. Figure 11 plots the calculated surface doses of the two codes as a function of 
the electron cutoff energy. The predicted surface doses converge as the electron cutoff 
energy is reduced, confirming that the differences in how the codes deal with electron 
transport at cutoff energies is the cause of the surface dose differences. For all other 
calculations in this thesis, DOSXYZnrc was run with an electron cutoff energy of 189 
keV kinetic energy, the standard cutoff energy for the clinic at VCU. VMC++ was run 
with its own computed cutoff energy, usually in the vicinity of 880 keV for water 
phantoms or 300 keV for heterogeneous patient geometries. 
Output factors computed by DOSXYZnrc and VMC++ were compared to those 
obtained with experimental data collected using IC3 ion chambers in a Wellhofer 3d 
water phantom. Figure 12 and Figure 13 show the results for the 6MV and 18MV beams 
respectively. The difference between the Monte Carlo-computed output factors and 
experiment for the 1x1 cm2 field at energy 6mv may be attributed to the uncertainty 
involved in positioning of the dosimeter in experiment. The difference might also be 
corrected for by more precisely modeling the IC3 detector in the Monte Carlo 
ca lc~ la t ions .~~  
5 Phantom Geometric Validation 
5.1 Introduction 
In order to properly integrate a Monte Carlo code, geometric validation must be 
performed.31 Since the accelerator beam head and the phantom have different coordinate 
systems (see Figure 14), the TPS must carry out coordinate transformations. Therefore, 
when the TPS simulates a beam, it must be verified that VMC++ reads in the beam at the 
proper location and at the proper angle in relation to the phantom, so that the dose will be 
displayed in the correct location. 
When performing geometric validation, irregularity allows for easier verification. 
If one were to use a square symmetric field orthogonally incident on a cubic phantom, 
there could be several possible false positive outcomes: essentially two wrongs could 
possibly make a right due to degenerate results. Therefore, it is important to use an 
asymmetric field incident on an irregular phantom at an odd angle with the isocenter not 
located at the center of the phantom. If each side of the phantom is uniquely irregular, 
any degenerate results would be eliminated. 
Several tests must be carried out for successful geometric validation. First of all, 
the gantry, collimator, and couch angles must each be tested separately at unique angles. 
Next, there should be a test in which all three angles are tested together at unique angles 
to ensure that there is no error introduced by coupling multiple rotations. Finally, a test 
must be carried out to test that the SSD is being set properly. A summary of these tests 
may be seen in Table 1. 
5.2 Method 
Pinnacle was used to simulate a 6MV photon beam with a field shape as seen in Figure 
15. By hand-drawing the contour of the water phantom, unique irregularity was ensured 
for each side of the phantom, as well as for every slice through the phantom. The 
isocenter was placed on the face of the phantom into which the beam was directed. The 
source-to-axis distance (SAD) was set to 100cm, resulting in a source-to-surface distance 
(SSD) of lOOcm as well. Voxel sizes were set to 0.5 x 0.5 x 0.5 cm3. For the gantry 
angle test, the gantry angle was set to 53', while all other angles were set to 0'. For the 
collimator angle test, the collimator angle was set to 12S0, while all other angles were set 
to 0'. For the couch angle test, the couch angle was set to 12', while all other angles were 
set to 0'. For the multiple angle test, the gantry angle was set to 53', the collimator angle 
to 12S0, and the couch angle to 12'. For the SSD test, the SSD was set to 60cm, while all 
angles were set to 0'. VMC++ was run to a nominal statistical uncertainty of five percent 
in all tests. 
5.3 Results 
All transverse, sagittal, and coronal slices were scanned through visually, and the dose 
distribution was found to line up with the aperture outline indicated by Pinnacle. Also, the 
expected dose fall-off was observed in the air cavities scattered throughout the phantom. Sample 
transverse, sagittal, and coronal slices may be seen for the gantry angle test, collimator angle test, 
couch angle test, multiple angle test, and SSD test in Figure 16, Figure 17, Figure 18, Figure 19, 
and Figure 20, respectively. 
6 Dosimetric Validation and Comparison 
In order to verify that VMC++ predicts correct dose distributions, comparisons 
must be made either with experiment or with a Monte Carlo code which has been well 
benchmarked against experiment, in this case DOSXYZnrc. In order to compare the two 
dose distributions, four methods were used. First of all, dose profiles were created to 
provide a visual check. However, since dose profiles only offer a two-dimensional 
comparison, two other comparison tools, gamma indices and a Kawrakow-Fippel method, 
were also used. Finally, dose volume histograms (DVHs) were produced for patient 
cases. 
6.1 Gamma Indices 
Gamma indices were first introduced as a means of quantitative comparison of two dose 
distributions by Dan Low in 1 9 9 8 ~ ~ .  This method combines the dose difference method 
and the distance-to-agreement (DTA) method. The dose difference method simply 
produces a percent difference between the two dose distribution values on a voxel-by- 
voxel basis. The weakness of this method occurs in areas of steep dose gradient, where a 
slight lateral offset of the distributions results in a large percent dose difference. The 
DTA method accounts for this weakness by finding the closest voxel of agreement 
between the two distributions. Therefore the DTA method produces a voxel-by-voxel 
grid of distances. When encountering a steep dose gradient, while the dose difference 
method could result in a large difference, the DTA method could result in a small 
difference, on the order of millimeters. The weakness of the DTA method occurs, 
however, in areas of shallow dose gradients. In this case, whereas the dose difference 
method would produce a relatively small percent difference, the DTA method may 
produce a large distance-to-agreement between voxels. One possible way to combine the 
two methods is by creating a grid which shows where either one of the two methods 
creates a passing score (i.e. 2%, 2mm). As long as a voxel has less than a 2% difference 
or less than a 2mm DTA, it will be given a passing value. If the voxel fails both tests, 
then it will receive a failing value. The problem with this combination of the two 
methods is that it is a binary system: it would be difficult to determine the magnitude of 
failure for each voxel. To compensate for this issue, introduced the gamma index, 
a non-binary combination of the dose difference and DTA methods. Table 2 shows the 
derivation of the gamma index. Similar to the binary system mentioned above, dose 
difference and DTA criteria are set for the gamma analysis. A voxel has an acceptable 
tolerance if its gamma index is less than one. Code was written by Fix to implement 
gamma analysis at VCU. 
Before conclusions may be drawn using gamma analysis between two dose 
distributions calculated by two different Monte Carlo codes, it is important to know what 
the gamma analysis yields when comparing two dose distributions calculated by a single 
Monte Carlo code. Pinnacle was used to simulate two identical 10x10 cm2 6MV beams 
orthogonally incident on a water phantom. VMC++ was then used to calculate the 
absorbed dose in the phantom for each beam. A gamma analysis was performed on the 
resulting dose distributions. The results, seen in Table 3, show that for the 1% / lmm 
criteria, only 99.3% of the voxels passed the gamma analysis. This percentage may be 
used as a reference when using gamma analysis to examine differences between 
distributions produced by different codes. 
6.2 Kawrakow-Fippel Method 
Kawrakow and Fippel introduced another means of quantitatively comparing dose 
distrubitions in 1 9 9 9 ~ ~ .  They defined xik 
as the dose difference between the reference and evaluated distributions in voxel ijk 
divided by the combined statistical uncertainty ADijk (summed by quadrature). If the two 
distributions only differed randomly, then X Q ~  would be fitted well by a Gaussian function 
centered at zero. In the case that systematic deviation existed between the two 
distributions, the moments of the distribution of x ~ k  yielded information concerning the 
amplitude and frequency of voxels containing significant systematic deviation. 
Kawrakow and Fippel used a fitting function to interpret the X Q ~  distribution. The 
probability distributionflx) to find a voxel with a deviation of x was given by 
Simply put, a fraction a, of the voxels had a systematic deviation of 8, , another fraction 
a; had a systematic deviation of a,, and the rest of the voxels had no systematic 
deviation. By fitting the probability distribution to X Q ~ ,  a quantitative comparison may be 
made between two dose distributions. 
6.3 Dose Volume Histograms 
For patient geometries, another method to compare two dose distributions is found in 
dose volume histograms (DVHs). With this method, the dose received to important 
structures, such as the gross tumor volume or the spinal cord, is plotted on the x-axis 
against the volume of the structure receiving a level of dose on the y-axis. The volume 
may be normalized such that it displays the proportion of the structure that is receiving a 
level of dose. Also, the DVHs for two distributions may be plotted on the same graph, 
making for a good visual comparison. 
6.4 Phantom Case 
Pinnacle was used to create a 10x10 cm2 6MV photon beam orthogonally incident on a 
rectangular water phantom (48cm x 48cm x 41cm depth). Voxel sizes were set to 0.5 x 
0.5 x 0.5 cm3 and completely covered the depth of the phantom while also covering 46 
cm of the 48 cm length and width. Both the DOSXYZnrc and the VMC++ codes were 
run to one-half percent nominal statistical uncertainty using the mcvmc family of codes 
discussed in section two. The VMC++ photon-splitting factor was set equal to that used 
by DOSXYZnrc. The 'Clean Up' flag was left unchecked, allowing for re-use of the 
exact same particles from phase space in both codes. 
Depth dose profiles were generated along the beam axis and may be seen above 
(Figure 8, Figure 9, and Figure 10). Also, lateral profiles were produced at depths of 2cm, 
5cm, and lOcm for the 10x10 cm2 6MV beam. The lateral profiles in the x-direction of 
the patient coordinate system may be seen in Figure 21, while the lateral profiles in the z- 
direction of the patient coordinate system may be seen in Figure 22.  The DOSXYZnrc 
and VMC++ dose profiles agreed well with each other, with the exception of the 
difference in surface dose mentioned earlier. 
The gamma index results are seen in Table 4 for voxels with dose greater than 
fifty percent of the maximum dose (recommended by Rogers and   oh an^^). Whereas 
100% of the voxels passed the 2% 1 2  rnrn criteria, 98.6% passed the 1% / lmm criteria. 
A sagittal slice of the gamma distribution revealing the surface dose difference may be 
seen in Figure 23. MATLAB was used to fit the data for the Kawrakow-Fippel method 
results. The fit may be seen in Figure 24. According to the fit, a fraction a, = 0.4 of the 
voxels have a systematic difference of 6, = 0.27 standard deviations. The value for a, 
corresponded to zero. The remainder of the voxels showed no systematic deviation. 
Since the standard deviation in this case referred to a combined nominal statistical 
uncertainty of 0.7%, the difference corresponds to a 0.2% difference of the maximum 
dose, which is insignificant. 
The total CPU time required to run the DOSXYZnrc calculation was just over one 
day. The total CPU time required to run the VMC++ calculation was about forty-five 
minutes. Accounting for subtle differences in respective variances, VMC++ yielded an 
efficiency approximately 37 times greater than that of DOSXYZnrc. It should be noted 
that a greater gain in efficiency would be possible if the photon-splitting factor of 
VMC++ were set to an optimal level instead of using the value set by DOSXYZnrc. 
6.5 Patient Case 
A comparison between DOSXYZnrc and VMC++ was also carried out in a patient case 
to observe how VMC++ performed in a more complex situation (i.e. with several IMRT 
fields incident on a heterogeneous phantom). A head-and-neck (WN) patient plan was 
loaded into Pinnacle for this comparison. The plan incorporated nine IMRT beams 
located at gantry angles of 0°, 30 O, 125 O, 165 O, 190 O, 235 O, 270 O, 300 O and 330 O. The 
dose grid had voxel sizes of 0.4 x 0.4 x 0.4 cm3, the standard voxel size for patient dose 
computations at VCU. The same particles from phase space were used in both the 
DOSXYZnrc case and the VMC++ case. However, the transport of these particles 
through the DMLC effectively differentiated them before they interacted with the patient 
geometry, since different random seeds were generated for each simulation of transport 
through the DMLC. 
The gamma index results comparing the DOSXYZnrc and VMC++ total dose 
distributions are seen in Table 5, as well as a sagittal slice of the distribution in Figure 25. 
Whereas 99.1% of the voxels passed the 2% / 2 mm criteria, only 86.4% passed the 1% / 
lmm criteria. The only areas in which the gamma index was greater than one were in air 
cavities within the body or in the air directly in front of the surface of the patient. 
MATLAB was used to fit the data for the Kawrakow-Fippel method results. The 
fit may be seen in Figure 26. According to the fit, a fraction a, = 0.0528 of the voxels 
had a systematic difference of S, = 4.06 standard deviations. The value for cl; 
corresponded to zero. The remainder of the voxels showed no systematic deviation. 
Since the standard deviation in this case referred to a combined statistical uncertainty of 
0.7% of maximum dose of the two calculations, the difference corresponds to a 2.8% 
difference of the maximum dose. When combined with the results of the gamma index 
display, it is seen that these voxels are located mostly in air cavities within the patient. 
The DVHs comparing the two distributions may be seen in Figure 27. VMC++ 
noticeably underpredicted DOSXYZnrc. The dose to 90% (D90) of the clinical target 
volumes (CTVs) agrees within one percent. 
The total CPU time required to run the DOSXYZnrc calculation was just over two 
and a half days. The total CPU time required to run the VMC++ calculation was about 
two hours. Accounting for subtle differences in respective variances, VMC++ yielded an 
efficiency approximately 35 times greater than that of DOSXYZnrc. 
7 Dose-to-Water Analysis 
Historically, dose measurements have been computed in terms of dose-to-water 
(Dwakr). Even though the human body is comprised of a variety of tissues, clinically the 
absorbed D,, is used. However, most Monte Carlo codes calculate dose-to-material 
(Dm,rial) instead of Dwakr, since they are transporting through patient materials. There is 
debate as to whether continuing to use D,,,, or starting to use Dmkrial should be done. In 
any case, an algorithm is required to convert Dmterial to Dwarer in scenarios when dose 
distribution comparisons are desired. 34,35 
One of VMC++'s capabilities is to directly convert Dmteria1 to D,, during 
execution of the transport. VMC++'s computation of Dwakr was compared to an in- 
house algorithm developed by Siebers et According to Bragg-Gray cavity theory, 
- 
S 
where (-)water is the unrestricted water-to-material mass collision stopping power 
P 
averaged over the energy spectra of electrons at the point of interest. Siebers found that 
S water varies less than one percent throughout a photon radiation field for a given 
P 
photon beam energy. Therefore, a simple material dependent post-processing 
multiplicative factor can be used to convert Dmakrial to D,, for a given photon beam 
energy. 
VMC++ converts Dmakrial to DWakr during execution of the transport on a track- 
by-track basis, not as a post-processing step. As the electron is transported through the 
geometry, Bragg-Gray cavity theory is utilized to compute D,, by multiplying the 
energy deposited by the ratio of stopping powers. In VMC++ all energy-dependent 
quantities are evaluated at a randomly distributed energy between the initial and final 
energies of the step. In the case of computing D,a,r, therefore, the energy deposition by 
an electron track in a voxel is multiplied by the ratio of stopping powers evaluated at a 
random energy between that of the electron entering the voxel and that of the electron 
exiting the voxel. 
To compare the Dwafer computation methods, the same patient plan described in 
section 5.4 was used. VMC++ was run to produce a dose distribution in terms of D,,,,,. 
VMC++ was also run to produce a dose distribution in terms of Dmferial. The resulting 
Dmate~al  was converted to Dwakr using the in-house algorithm. The two distributions were 
then compared using gamma analysis for voxels with dose greater than fifty percent of 
the maximum dose. Also, the distributions were compared using the Kawrakow-Fippel 
method. Finally, respective DVHs were produced. 
Results of the gamma analysis are seen in Table 6. Whereas 99.8% of the voxels 
passed the 2% / 2 mm criteria, 99.5% passed the 1% / lmm criteria. It should be noted 
that these results lie within the bounds of statistical uncertainty calculated in section 6.1. 
MATLAB was used to fit the data for the Kawrakow-Fippel method results. The fit may 
be seen in Figure 28. According to the fit, a fraction al = 1.0 of the voxels have a 
systematic difference of 6, = 0.17 standard deviations. The value for oc, corresponded to 
zero. The VMC++ internal DWakr calculation seems to slightly underpredict the VCU in- 
house conversion. However, since the standard deviation in this case refers to a 
combined nominal statistical uncertainty of 0.7% of the two calculations, the difference 
corresponds to a 0.1 % difference of the maximum dose. This difference is insignificant 
compared to the systematic error introduced by the in-house algorithm, which 
S 
approximates that (-Iwater does not vary throughout a photon radiation field, when in 
P 
fact it does by up to one percent. The comparison DVH, seen in Figure 29, shows that 
the differences between the two methods are visually indiscernible. The DgO of the CTVs 
agrees within 0.1 percent. 
8 Conclusion & Future Work 
VMC++ was integrated into a commercial TPS at VCU and benchmarked against 
DOSXYZnrc. Output factor normalization was performed, yielding agreement within 
1% of experiment for all field sizes except 1x1 cm2. Geometric validation was carried 
out on an irregular water phantom, and showed that VMC++ properly aligned the beam 
on phantom geometry. VMC++ dose calculations were compared to DOSXYZnrc dose 
calculations for a simple water phantom and a complex nine-field IMRT H/N patient case. 
The VMC++ dose distribution differed insignificantly with that of DOSXYZnrc for the 
water phantom case. For the patient case, 5.28% of the VMC++ voxels deviated from the 
DOSXYZnrc voxels by 4.06 standard deviations. Considering the combined statistical 
uncertainty of 0.7%, this resulted in a 2.8% difference of maximum dose. This result 
warrants further investigation (see following paragraph) since the difference between the 
two codes exceeds the proposed criteria of ICRU report 4236 of 2% of maximum dose. 
When the gamma index was plotted in the patient geometry, it was seen that the voxels 
which failed the gamma analysis were located mostly in air cavities within the body. The 
internal dose-to-water conversion of VMC++ was investigated by comparing it to a VCU 
in-house conversion. The two resulting dose distributions strongly agreed, with 99.5% of 
the voxels passing the gamma analysis within 1% / lmm criteria, and the resulting 
differences in DVHs were visually indiscernible. 
Future investigation should be performed concerning the discrepancy between the 
dose distributions calculated by DOSXYZnrc and VMC++ for the H/N patient case. A 
proposed flow chart for this investigation is seen in Figure 30. Results of this thesis show 
that DOSXYZnrc and VMC++ agree within statistical uncertainty for the simple case of a 
10x10 cm2 field orthogonally incident on a water phantom. The next step would be to 
test if the presence of materials other than water is causing disagreement between the two 
codes. This test ('test A') would be accomplished by having a 10x10 cm2 field 
orthogonally incident on a heterogeneous phantom. If test A were to fail, the next step 
('test B') would be to change the CT ramp from the 56-material ramp to the simplistic CT 
ramp that was predefined in VMC++. If test B were to fail, it could be concluded that 
there is a problem with implementation of VMC++, since previous studies have shown 
that DOSXYZnrc and VMC++ agree in a test case similar to test B . ~ '  If test B were to 
show agreement, it could be concluded that there is a problem in the implementation of 
the 56-material CT ramp. If test A were to show agreement, the next step ('test C') 
would be to test if the presence of field sizes besides 10x10 cm2 is causing the 
discrepancy. This would be accomplished by simulating one beam from the H/N patient 
plan at 0' on a water phantom, except with the IMRT turned off. If test C were to fail, it 
could be concluded that there is a problem in the implementation of field sizes. If test C 
were to show agreement, the next step ('test D') would be to rerun test C with IMRT 
turned on. If test D were to fail, it could be concluded that there is a problem in the 
implementation of IMRT, perhaps how VMC++ is reading in the weights of the incident 
particles. If test D were to show agreement, the next step ('test E') would be to test if the 
presence of various incident beam angles besides 0' is causing the discrepancy. Test E 
could be performed by simulating the entire H/N patient plan on a water phantom. If test 
E were to fail, the next step ('test F') would be to perform a beam-by-beam analysis of all 
the beams in the H/N patient plan. If test F were to result in significantly different levels 
of agreement among all the beams, the next step would be to determine what 
differentiates one beam from the next. If test E were to show agreement, the next step 
('test G') would be to test if the presence of the patient's outer contour is causing the 
discrepancy by replacing the water phantom with the patient geometry composed entirely 
of water. If test G were to fail, it could be concluded that the patient's outer contour is 
causing the discrepancy. If test G were to show agreement, the next step ('test H') would 
be to test if the patient materials and internal geometry are causing the discrepancy. Test 
H would be accomplished by calculating the dose distributions for the H/N patient plan 
on the H/N patient geometry and materials. If test H were to fail, the next step ('test 1') 
would be to test a prostate plan on patient geometry to observe if the discrepancy is 
specific to the H/N patient plan. If test I were to fail, it could be concluded that the 
combination of patient materials with inner geometry is causing the discrepancy. If test I 
were to show agreement, it could be concluded that the discrepancy is H/N patient 
geometry specific. Finally, if test H were to show agreement, the discrepancy would be 
resolved. To expedite the testing process, the tests should not be performed in order, but 
instead each subsequent test should be halfway between the tests with known results. 
Figures 
Table 1: Summary of tests for geometric validation. 
Table 2: Definitions of the gamma function.32 
Test 
Unique gantry angle 
Unique collimator angle 
Unique couch angle 
Unique gantry, collimator, and couch angles 
Change the SSD 
Symbol Equation Description 
De(<) N/ A Evaluated dose D, at position < 
Reasoning 
Validate that VMC++ is positioning the 
gantry angle correctly. 
Validate that VMC++ is positioning the 
collimator angle correctly. 
Validate that VMC++ is positioning the 
couch angle correctly. 
Validate that VMC++ is positioning all 
angle correctly without introducing error 
due to angle coupling. 
Validate that VMC++ correctly places 
the phase space of incident particles at 
the proper location. 
D,(<> N/A Reference dose D, at position < 
Dose difference criterion 
Distance-to-agreement criterion 
Spatial distance between 
evaluated and reference dose 
points 
&<,<)  &<,<)  = De(<)-Dr(<) Difference between evaluated 
dose De(<) at position < and 
reference dose D, (<) at position 
Generalized r function, 
computed for all evaluated 
positions < and reference 
positions < 
Y(<) y(<) = f i n { u < , < ) } w < }  y function, the minimum 
generalized r function in the set 
of evaluated ~oin t s  
Table 3: Gamma analysis results for comparison between two VMC++ dose distributions 
for a 6MV 10x10cm2 beam incident on a water phantom. Only voxels with dose greater 
than fifty percent of maximum dose were included in the analysis. 
Table 4: Gamma analysis results for comparison between DOSXYZnrc and VMC++ 
dose distributions for a 6MV 10x10cm2 beam incident on a water phantom. Only voxels 
with dose greater than fifty percent of maximum dose were included in the analysis. 
Dose differenceDTA Criteria 
2% / 2mm 
1% / lmm 
Table 5: Gamma analysis results for comparison between DOSXYZnrc and VMC++ 
dose distributions for a nine-beam IMRT plan on a head-and-neck (WN) patient. Only 





Dose differenceDTA Criteria 
2% /2mm 
1% / lmm 
Mean gamma value 
0.135 
0.264 
Table 6: Gamma analysis results for comparison between VMC++ Dmzerial plus an in- 
house conversion to DWazer and VMC++ Dwakr for a nine-beam IMRT plan on a H/N 
patient. Only voxels with dose greater than fifty percent of maximum dose were included 




Dose differenceDTA Criteria 
3% / 3mm 
2% / 2mm 
1% / lmm 







Dose differenceDTA Criteria 
2% / 2mm 






Mean gamma value 
0.155 




Figure 1: Probability density function for collision sampling. In this case, a 6 MeV 
photon is traveling through a water medium. The computer will randomly sample a 
number on the range [0,1]. The most probable interaction is a Compton effect (yellow 
band), which will be sampled roughly 88% of the time. Pair production (light blue band) 
will be sampled about 12% of the time. The less probably cross-sections are seen in the 
inset located at the lower left side of the figure. Even though the cross-sections for 
photoelectric effect (blue-purple band) and Rayleigh/Thomson scattering (maroon band) 
are on the order of lo-', these events will be selected when running Monte Carlo for 






head simulation , BEAMnrc 
run Monte Carlo 
dose calculation VMC++ 
merge the n dose files 
Figure 2: Basic flow diagram for the mcvmc process. The user selects the 
mcvmc.vmc.tc1 script to run mcvmc. The user-specified flags and values are passed to 
mcvmc by tcl-to-mcv. The input is split n times to be divided among processors. The 
user-specified accelerator head simulation is carried out followed by the user-specified 
Monte Carlo dose calculation. After the dose files are merged together, the dose is 
displayed in Pinnacle. It should be noted that this is a simplified flow diagram, which 
does not include other available options such as running the particles through the 
dynamic multileaf collimator or using an electronic portal imaging device after transport 
through the phantom geometry. 
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Figure 3: GUI resulting from mcvmc.vmc.tc1 for a five beam treatment plan (beams 
named Beam-1, Beam-2, . ..; trial named Trial-1). In this case, particle transport and 
dose deposition will be performed for Beam-1 and Beam-3. To set other options, the 
different Config menus must be accessed. 
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Figure 4: The general config menu created by mcvmc.vmc.tc1. The user can choose the 
desired Monte Carlo code to use (dosxyz, dosxyznrc, mcvrtp, vmc++) by clicking on the 
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Figure 5: The DMLC config menu created by mcvmc.vmc.tc1. The user can specify 
whether or not IMRT is being used, and which code to run the particles through the 
multi-leaf collimator. 
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Figure 6: The VMC++ config menu created by mcvmc.vmc.tc1. Dose-to-water or dose- 
to-material may be chosen. The user can also choose what type of simulation (source 
model or phase space) to use, as well as if they wish to match photon splitting from 
DOSXYZnrc or set it independently. 
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Figure 7: The research config menu created by mcvmc.vmc.tc1. The user may choose to 
use new particles for transport by checking the 'Clean Up' option. 'Beta Version' may 
be checked to test new code safely. 
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Figure 8: Com arison of DOSXYZnrc and VMC++ depth doses (cGy1MU) for 40x40 B cm2, 10x10 cm , and 1x1 cm2 fields at energy 6MV. The lower plots are the respective 
percent error plots, calculated using the formula: 
%Error = ( DDOSXYZnrc - D ~ ~ ~ + +  ) I DDOSXYZnrc * 100% , since DOSXYZnrc was considered the 
standard with which to compare VMC++. Statistical uncertainty was propagated by 
summing by quadrature. The error bars in all plots correspond to two times the standard 
deviation. 
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Figure 9: Comparison of DOSXYZnrc and VMC++ depth doses (cGy1MU) for 20x20 
cm2, 4x4 cm2, and 2x2 cm2 fields at energy 6MV. The lower plots are the respective 
percent error plots, calculated using the formula: 
%Error = (D,, - Dw,++) l D,, * 100% . Statistical uncertainty was propagated 
by summing by quadrature. The error bars in all plots correspond to two times the 
standard deviation. 
Depth Icm) 
Figure 10: Comparison of DOSXYZnrc and VMC++ depth doses (cGyIMU) for 40x40 
cm2, 10x10 cm2, and 1x1 cm2 fields at energy 18MV. The lower plots are the respective 
percent error plots, calculated using the formula: 
%Error = ( D D O S X ~ ,  - DvMc++) 1 D D O S X ~ ,  * 100% . Statistical uncertainty was propagated 
by summing by quadrature. The error bars in all plots correspond to two times the 
standard deviation. 
Figure 11: Comparison of DOSXYZnrc and VMC++ surface doses (cGy/MU) for 10x10 
cm2 field at energy 6MV. The surface doses calculated by the two codes converge as the 
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Figure 12: Output factor comparison between DOSXYZnrc, VMC++, and measurement 
for various field sizes and energy 6MV. The difference in the 1x1 cm2 field may be 
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Figure 13: Output factor comparison between DOSXYZnrc, VMC++, and measurement 
for various field sizes and energy 18MV. 
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Figure 14: Beam and patient coordinate systems. In order to transform from beam 
coordinates to patient coordinates, each particle's position and direction must be 
multiplied by a rotation matrix to properly account for gantry, collimator, and couch 
rotations. 
1 cm 3 cm 
2 ctn 
Figure 15: Irregular field shape used for phantom geometric validation. 
The black dot shows the beam axis. 
Figure 16: Transverse, sagittal, and coronal view of dose distribution computed by 
VMC++ for a gantry angle of 53'. Note how the distribution lines up with the projected 
aperture. Also, note the dose fall-off when the beam encounters air cavities within the 
phantom. 
Figure 17: Transverse, sagittal, and coronal view of dose distribution computed by 
VMC++ for a collimator angle of 128'. Note how the distribution lines up with the 
projected aperture. Also, note the dose fall-off when the beam encounters air cavities 
within the phantom. 
Figure 18: Transverse, sagittal, and coronal view of dose distribution computed by 
VMC++ for a couch angle of 12". Note how the distribution lines up with the projected 
aperture. Also, note the dose fall-off when the beam encounters air cavities within the 
phantom. 
Figure 19: Transverse, sagittal, and coronal view of dose distribution computed by 
VMC++ for a gantry angle of 53", collimator angle of 128", and couch angle of 12". Note 
how the distribution lines up with the projected aperture. Also, note the dose fall-off 
when the beam encounters air cavities within the phantom. 
Figure 20: Transverse, sagittal, and coronal view of dose distribution computed by 
VMC++ for an SSD of 60cm. Note how the distribution lines up with the projected 
aperture. Also, note the dose fall-off when the beam encounters air cavities within the 
phantom. 
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Figure 21: Comparison of DOSXYZnrc and VMC++ lateral profiles in the x-direction of 
the patient coordinate system for a 10x10 cm2 field at energy 6MV. The lower plots are 
the respective percent error plots, calculated using the formula: 
%Error = (D,,,,, - D,,,,,) 1 D,,,,, "100%. Statistical uncertainty was propagated 
by summing by quadrature. The error bars in all plots correspond to two times the 
standard deviation. 
- 5cm depth 
DOSXYZnrc FI
Figure 22: Comparison of DOSXYZnrc and VMC++ lateral profiles in the z-direction of 
the patient coordinate system for a 10x10 cm2 field at energy 6MV. The lower plots are 
the respective percent error plots, calculated using the formula: 
%Error = (D,, - D,,,,,) l D,, * 100% . Statistical uncertainty was propagated 
by summing by quadrature. The error bars in all plots correspond to two times the 
standard deviation. 
Figure 23: Gamma index results displayed on top of the water phantom. 
The beam axis is shown by the dashed red line. Gamma index criteria 
were 1% / lmm in this case. The only area where the gamma index was 
greater than one was on the front face of the phantom. Note that the 
misalignment between the phantom surface and the dose grid (dashed 
green line) is a visual quirk of Pinnacle: mathematically, the two line up 
exactly. 
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Figure 24: Fit of the dose distribution comparison. The fit determined that 60% of the 
voxels had no systematic deviation between the two codes, while the remaining 40% of 
the voxels had a difference of 0.27 standard deviations. In this case the standard 
deviation is equal to the combined nominal statistical uncertainty, 0.7%. Therefore, the 
difference between the two distributions (0.2%) is insignificant for the differing 40% of 
the voxels. The reason the fit seems slightly too broad is due to the lack of accounting 
for cross-correlation when calculating the combined statistical uncertainty in each voxel. 
Figure 25: Gamma index displayed on top of a H/N patient for which a 
nine-beam IMRT plan was used. Criteria were 2% 1 2mm in this case. 
The only areas where the gamma index was greater than one were air 
cavities in the patient. 
Dose Distribution Comparison 
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Figure 26: Fit of the dose distribution comparison. The fit determined that 
approximately 95% of the voxels had no standard deviation between the two codes, while 
the remaining 5% of the voxels had a difference of 4.06 standard deviations. In this case 
the standard deviation is equal to the combined nominal statistical uncertainty, 0.7%. 
Therefore, the difference between the two distributions is 2.8% for the differing 5% of 
the voxels. The reason the fit seems slightly too broad is due to the lack of accounting 
for cross-correlation when calculating the combined statistical uncertainty in each voxel. 
Patient DVH Comparison 
Physicist 
Figure 27: DVH comparing DOSXYZnrc dose calculation (solid lines) with V M C u  
(dashed lines) for the spinal cord (black), the nodes (blue), clinical target volumes (CTVs) 
(red), and gross tumor volumes (GTVs) (green). VMC++ noticeably underpredicts 
DOSXYZnrc for the GTVs, CTVs, and nodes. 
Dose Distribution Comparison 
Kawrakow-Elppel Ansatz 
Figure 28: Fit of the dose distribution comparison. The fit determined that all of the 
voxels had a systematic bias of 0.17 standard deviations. In this case the standard 
deviation was equal to the combined statistical uncertainty, 0.7%. Therefore, the 
difference between the two distributions (0.1 %) is insignificant. The reason the fit seems 
slightly too broad is due to the lack of accounting for cross-correlation when calculating 
the combined statistical uncertainty in each voxel. 
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Figure 29: DVH comparing the VMC++ D,,,, dose calculation (solid lines) with the 
dose calculation produced by running the in-house conversion to Dwater on the VMC++ 
dose calculation (dashed lines) for the spinal cord (black), the nodes (blue), the 
CTVs (red), and the GTVs (green). Differences between the two calculations are nearly 
indiscernible. 
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Figure 30: Flow chart to determine the cause of discrepancy between DOSXYZnrc and 
VMC++ for WN patient case. Solid green arrows represent agreement between the two 
codes, while dashed red arrows represent disagreement. Each box represents a test case 
between the two codes which has been designed to answer the respective question in 
italics. 
Appendix 
Sample VMC++ Input File 
# Autogenerated config file 
:start general source: 
monitor units source-1 = 1 
:start vcuPhaseSpace source: 
my name = source-1 
gantry angle = 270 / /  set the angles 
couch angle = 0.000000 
collimator angle = 345 
isocenter coordinates = 22.13 31.25 123.70 / /  set the isocenter 
file name = unknownSourceFileName / /  phase space file name 
phaseSpaceZ = unknownSourceDistance / /  distance to phase space 
:stop vcuPhaseSpace source: plane; to be set later 
:stop general source: 
:start geometry: 
:start XYZ geometry: 
my name = xyz 
method of input = MMC-PHANTOM 
phantom file = unknownPhantomFileName / /  phantom file name; 
:stop XYZ geometry: to be set later 
:stop geometry: 
:start scoring options: 
start in geometry: xyz  
:start dose options: 
score in geometries: xyz 
score dose to water: no 
:stop dose options: 
:start output options xyz: 
dump dose: 1 
:stop output options xyz: 
:stop scoring options: 
:start MC Parameter: 
automatic parameter = yes 
:stop MC Parameter: 
:start MC Control: 
required uncertainty = 1.5 
insertNCaseHere 
:stop MC Control: 
:start variance reduction: 
repeat history = 0.041 
split photons = 1 
photon split factor = unknownPhotonSplitFactor / /  set photon-split 
:stop variance reduction: factor 
:start quasi: 
base = 2 / /  set quasi-random values 
dimension = 60 
skip = 1 
:stop quasi: 
/ /  Dwater or Dmat set here 
/ /  nominal uncertainty 
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